Ascendis Pharma A/S (ASND)
NASDAQ·Healthcare·Biotechnology
$263.93
+1.03%
Mkt Cap $14.73B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (55 analysts)
$320.36
Range $273.00 – $345.00
Implied Upside
+21.4%
Consensus $320.36 vs current $263.93
NASDAQ·Healthcare·Biotechnology
$263.93
+1.03%
Mkt Cap $14.73B
Buy
5
Hold
0
Sell
0
Price Target (55 analysts)
$320.36
Range $273.00 – $345.00
+21.4%
Consensus $320.36 vs current $263.93